[Hypotensive effects of diltiazem in DOCA/saline hypertensive rats (author's transl)].
D000284:Administration, Oral; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents; D001552:Benzazepines / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D003900:Desoxycorticosterone; D004110:Diltiazem / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D007275:Injections, Intravenous; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D012083:Renin / Q000097:blood; D012965:Sodium Chloride; D014237:Trichlormethiazide / Q000494:pharmacology
D000959:Antihypertensive Agents; D001552:Benzazepines; D004338:Drug Combinations; D000804:Angiotensin II; D003900:Desoxycorticosterone; D012965:Sodium Chloride; D012083:Renin; D004110:Diltiazem; D014237:Trichlormethiazide; D009638:Norepinephrine